| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5614639 | Journal of Cardiology | 2017 | 5 Pages |
Abstract
This study will be the first multicenter trial to evaluate the effects of alogliptin on coronary atherosclerosis using the newly developed FFRCT as the primary endpoint, and the findings will clarify the anti-atherogenic effects of alogliptin.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Tsuyoshi MD, Kazuki MD, Takeshi MD, Takashi PhD, Kiyoshi MD, FJCC, Satoru MD, Ichiro MD, FJCC,